Company intelligence / Profile preview

Harvest

Israel

Ownership: Private
Development stage: Other

Overview

VINIA has undergone successful clinical trials and is generating significant revenues with over 50,000 active subscribers. The company is executing a clinical trial roadmap targeting specific blood flow-related conditions including brain and heart health, optic health, and sexual health.

Therapeutic areas: Infectious DiseasesCardiovascularNeurologyOphthalmology
Modalities: Plant-based small moleculesPlant cell compositionsBotanical synthesis products
Industry: Food & Nutrition

Partnerships

Tate & Lyle

Beyond the preview

Go deeper on Harvest.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Harvest.

Explore the full profile